3 things ASX investors should watch this week

The coming days are huge for your stock portfolio. Keep an eye on these developments.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As reporting season continues in earnest, if you are invested in ASX shares you need to pay attention.

Fortunately for The Motley Fool readers, eToro market analyst Josh Gilbert has pointed out the three biggest events to monitor this week:

Three business people stand on platforms in the desert and look out through telescopes.

Image source: Getty Images

1. Australia unemployment

The financial markets, the Reserve Bank of Australia (RBA), and the general public will all be watching for the latest unemployment figures on Thursday.

Gilbert pointed out that December's rise to 3.9% exceeded expectations.

"December's uptick was perceived as a sign that the labour market could be loosening up, with job advertisement figures dipping and population growth remaining robust, suggesting that we might see a further rise in unemployment this week."

Similar to the rate hikes over 2022 and 2023, Gilbert reckons the RBA will again fall behind compared to its peers.

"It's likely to be one of the last major central banks to introduce rate cuts this year."

2. CSL half-year results

Biotech giant CSL Ltd (ASX: CSL) has enjoyed a 32% rise in its share price since late October.

But it recently saw a setback that could have longer term implications.

"The company's share price faced a decline [last week] following news of a UK investigation into alleged anti-competitive behaviour from CSL Vifor. 

"If found guilty, CSL faces potential fines and reputational damage, which may impact the company's FY24 results."

The last reporting season was positive for the ASX healthcare company.

"Shareholders were pleased with the healthcare giant's FY23 results, where revenue growth went up 31% year-over-year to US$13.31 billion, and the company's FY24 guidance continued to hold firm."

On Tuesday morning, the market will be watching carefully how CSL is progressing in its underlying profit guidance of US$2.9 billion to US$3 billion for FY24.

"[Investors] are keen to ascertain whether CSL has sustained its course toward recovery following the turbulence its share price experienced in 2023."

3. Telstra half-year results

Another portfolio staple, Telstra Group Ltd (ASX: TLS) is reporting on Thursday.

According to Gilbert, the telco stock has been disappointing in recent times.

"It's been a lacklustre couple of years for Telstra, with shares falling by around 2% in that time, despite a 14% jump in profitability last year.

"This week's half-year results will be a key insight as to how cost-cutting has aided the businesses bottom line."

Gilbert is optimistic about the coming results, though.

"Telstra's profits look set to continue growing. 

"In August, the business forecasted an EBITDA of $8.2 billion to $8.4 billion in FY24, well ahead of FY23's $7.86 billion."

Motley Fool contributor Tony Yoo has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Wednesday

Will it be a good session for Aussie investors? Let's find out.

Read more »

An older couple enjoying their retirement come together in their warm heated home with fire cracker sparklers.
52-Week Highs

These ASX stocks have hit the ground running in June – can they keep rising?

Where to next for these red hot shares?

Read more »

A white EV car and an electric vehicle pump with green highlighted swirls representing ASX lithium shares
Broker Notes

Up 473% in a year, should I buy PLS shares today?

PLS – formerly Pilbara Minerals – leads the ASX 200’s top one-year gains board. But can the ASX lithium stock…

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Broker Notes

Why 4DMedical shares can return to record highs: Expert

Why it could be an ideal time to buy the dip on this exciting stock.

Read more »

Top ten gold trophy.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors weren't in a good mood this Tuesday.

Read more »

A child covering his eyes hiding from a toy bear.
Broker Notes

Brokers rate these 5 ASX 200 shares as a sell!

Find out why brokers are so bearish about these ASX 200 shares.

Read more »

a woman looks exhausted and overwhelmed as she slumps forward into her hand while looking at her laptop screen.
52-Week Lows

Are CSL and ResMed shares buys at 52-week lows?

These ASX healthcare shares may not regain investor confidence overnight, but I think they are worth studying while sentiment is…

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

WiseTech, Cochlear, CSL shares: Can these beaten down stocks rebound in 2026?

It looks like brokers have lost confidence in one of these shares.

Read more »